Nifty Outlook Report 11th July


Presentation Description

Equity Research Lab is an ISO 9001-2011 Certified And SEBI Registered one of the leading Stock Advisory Company, which Provides Stock Tips, Mcx Tips, Commodity Tips, Equity Tips, Forex trading on Mobile with High Accuracy.


Presentation Transcript

slide 1:

qwertyuiopasdfghjklzxcvbnmqwerty uiopasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjklzx cvbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmqwertyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmqwertyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmrtyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqwert yuiopasdfghjklzxcvbnmqwertyuiopas dfghjklzxcvbnmqwertyuiopasdfghjklz NIFTY OUTLOOK REPORT 11 th July 2017

slide 2:

11 th July 2017 WWW.EQUITYRESEARCHLAB.COM NIFTY INTRADAY CHART NIFTY OUTLOOK Name Current Value Change Chg Open High Low FTSE 100 Jul 10 7370.03 19.11 0.26 7350.92 7388.02 7344.31 CAC 40 Jul 10 5165.64 20.48 0.4 5160.70 5179.34 5147.67 DAX Jul 10 12445.92 57.24 0.46 12464.96 12482.95 12406.20 Nikkei 225 Jul 11 20173.21 92.23 0.46 20073.86 20179.78 20070.67 Straits Times Jul 11 3234.11 -12.24 -0.38 3248.55 3249.49 3230.58 Hang Seng Jul 11 25784.22 284.16 1.1 25605.19 25788.99 25596.21 Taiwan Weighted Jul 11 10385.81 95.9 0.92 10313.08 10392.25 10313.08 SGX Nifty Jul 11 9793.50 20.5 0.21 9776.00 9807.50 9759.00 NIFTY NIFTY FUT : R1:9800 R2:9825 R3:9850 PIVOT : 9752 S1:9712 S2:9647 S3:9607 Nifty is likely to open in a marginal positive note. Momentum indicators are indicating towards a strong trading session for bulls. Bulls are ready to show their hidden power after bear losses 9675 mark. Positional traders are advised to cover their shorts as we are expecting nifty to show up 10000 soon in upcoming trading sessions. Strategy: Buy nifty around 9760 with a stop loss of 9725 for the target of 9820.

slide 3:

11 th July 2017 WWW.EQUITYRESEARCHLAB.COM CORPORATE NEWS -Cadila Healthcare: Zydus gets tentative US FDA nod for Lurasidone Hydrochloride tablets -Alembic Pharmaceuticals receives USFDA tentative approval for Dabigatran Etexilate capsules -SBI board approves divestment of SBIs stake in SBI Life through an IPO offer for sale of 8 crore shares -Patel Integrated Logistics signs letter of intent to acquire a warehouse of 35000 square feet carpet area in Gujarat on 30-year lease basis with Sumar Logistics Industrial Park -Gallantt Metal - Ind-Ra affirms A- rating to companys long term borrowing -Accel Frontline completes sale of entire shareholding in Accel systems Singapore to Starhub -Ramco Systems - ICRA reaffirms the long term and short term credit ratings for bank facilities -Oriental Bank of Commerce revises 1-year MCLR rate to 8.45 percent from 8.5 percent -Global carriers PE hover around Jet Airways to acquire 24 percent stake: ET -SpiceJet - Ex-promoter Maran alleges contract violation “no question of dmamges” -GTL comes clean in audit lenders to settle debt: ET -DB Corp in talks to sell 2520MW power arm to Tata Power CDPQ ICICI venture: ET -Lanco Infratech encashes suppliers bank guarantees: BS -Inox Wind Suzlon Energy in focus - GST concerns delay renewable auction in Gujarat: FE-IOC Lanzatech sign statement of intent to construct gas-to-bioethol production unit in India

slide 4:

11 th July 2017 WWW.EQUITYRESEARCHLAB.COM ERL RESEARCH TEAM Member Name Designation E-mail ID Mr. Tuhinanshu Jain Research Head Mr. Manish Bimal Sr. Research Analyst DISCLAIMER The information and views in this report our website all the service we provide are believed to be reliable but we do not accept any responsibility or liability for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in Stocks has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We however do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it takes no responsibility whatsoever for any financial profit s or loss which may arise from the recommendations above. The stock price projections shown are not necessarily indicative of future price performance. The information herein together with all estimates and forecasts can change without notice. Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial instrument. Analyst or any person related to Equity Research Lab might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. Our Clients Paid or Unpaid any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of the information is the acceptance of this disclaimer. ALL RIGHTS RESERVED.

authorStream Live Help